| pubmed-article:474181 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0439849 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0002006 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C1524119 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0003009 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0013832 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C0085580 | lld:lifeskim |
| pubmed-article:474181 | lifeskim:mentions | umls-concept:C1150120 | lld:lifeskim |
| pubmed-article:474181 | pubmed:issue | 7 | lld:pubmed |
| pubmed-article:474181 | pubmed:dateCreated | 1979-10-17 | lld:pubmed |
| pubmed-article:474181 | pubmed:abstractText | Plasma concentrations of angiotensin II (AII) were studied in 36 patients with primary (essential) hypertension and 15 normotensive control subjects during basal (1 h supine rest), upright and frusemide-stimulated (80 mg orally) conditions. Plasma renin activity (PRA) and plasma aldosterone (PA) were determined on the same occasions. AII was then correlated statistically to PRA, PA and 24-hour urinary excretions of aldosterone (Aldo-U), sodium and potassium and to the blood pressure (BP) levels. The AII values in the hypertensive patients were not statistically significantly different from those in the normotensive subjects. A close relationship was found between the AII values and the corresponding PRA values in the hypertensive patients (r=0.65--0.76, p less than 0.001 for all). Correlations between AII and PA, and AII and Aldo-U were not consistently significant. No correlation was found between AII and BP or between AII and 24-hour urinary electrolytes. The findings point to an intact function between PRA and AII but a disturbed AII-aldosterone interrelation in primary hypertension. | lld:pubmed |
| pubmed-article:474181 | pubmed:language | eng | lld:pubmed |
| pubmed-article:474181 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:474181 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:474181 | pubmed:issn | 0001-6101 | lld:pubmed |
| pubmed-article:474181 | pubmed:author | pubmed-author:KarlbergB EBE | lld:pubmed |
| pubmed-article:474181 | pubmed:author | pubmed-author:TolagenKK | lld:pubmed |
| pubmed-article:474181 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:474181 | pubmed:volume | 205 | lld:pubmed |
| pubmed-article:474181 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:474181 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:474181 | pubmed:pagination | 557-62 | lld:pubmed |
| pubmed-article:474181 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-H... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-B... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-H... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-P... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-E... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-A... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-P... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-C... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-F... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-M... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-R... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-A... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-A... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-M... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-A... | lld:pubmed |
| pubmed-article:474181 | pubmed:meshHeading | pubmed-meshheading:474181-F... | lld:pubmed |
| pubmed-article:474181 | pubmed:year | 1979 | lld:pubmed |
| pubmed-article:474181 | pubmed:articleTitle | Angiotensin II in primary hypertension, relationship to plasma renin activity, aldosterone and urinary electrolytes. | lld:pubmed |
| pubmed-article:474181 | pubmed:publicationType | Journal Article | lld:pubmed |
